191 results on '"Nulsen, J."'
Search Results
2. GnRH agonist to induce oocyte maturation during IVF in patients at high risk of OHSS
3. Patient-specific cancer genes contribute to recurrently perturbed pathways and establish therapeutic vulnerabilities in esophageal adenocarcinoma
4. IVF outcomes for translocation carriers comparing fluorescence in-situ hybridization, microarray comparative genomic hybridization, and next-generation sequencing
5. Larger size of the oocyte cohort does not affect risk of embryo aneuploidy when using next generation sequencing (NGS)
6. Mixed stimulation protocols do not improve euploidy rates in embryos tested with next generation sequencing
7. Higher rates of mosaic only embryos found in younger patients evaluated by next generation sequencing
8. Decreased ovarian reserve biomarkers are associated with reduced fecundability in women with no history of infertility
9. Impact of trigger medication on aneuploidy rates
10. Is cleavage stage morphology necessary for selecting blastocysts for transfer?
11. Are pregnancy rates affected by day of blastocyst cryopreservation in single euploid frozen embryo transfer cycles?
12. Frozen transfer is superior to fresh transfer of screened, euploid embryos
13. Pregnancy outcomes between euploid and non-tested blastocysts in frozen embryo transfer cycles
14. Should we leave the past behind us? determining the role of static cleavage stage morphology in the selection of blastocysts for transfer
15. Old habits die hard: use of corticosteroids and antibiotics prior to embryo transfer
16. Prospective double-blind randomized placebo controlled clinical trial comparing pregnancy rates after co-administration of low dose HCG at the time of GnRH-agonist trigger or 35 hours later, for the prevention of OHSS
17. Successive single embryo transfer cycles lead to reduced risk without compromising success rates in women under 38
18. Development of personalized predictive models for non-IVF and IVF procedures in lesbian and single women sheds light on applicability of infertility biomarkers to women of unknown fertility status
19. Assisted reproductive technologies: utilization and reproductive choices by lesbian couples
20. The effect of insurance coverage on the utilization of frozen embryos in in vitro fertilization
21. Luteal phase luteinizing hormone (LH) levels after gonadotropin-releasing hormone agonist (GNRH-a) trigger and probability of conception
22. Peri-implantation whole-blood gene expression in in-vitro fertilization (IVF) compared to frozen embryo transfer (FET) cycles
23. Elective embryo cryopreservation after prolonged premature progesterone elevation to improve in vitro fertilization (IVF) pregnancy outcomes
24. Large, comparative, randomized double-blind trial confirming noninferiority of pregnancy rates for corifollitropin alfa compared with recombinant follicle-stimulating hormone in a gonadotropin-releasing hormone antagonist controlled ovarian stimulation protocol in older patients undergoing in vitro fertilization
25. Lipoprotein scavenger receptor class b type I: an important regulator of de novo cholesterol synthesis in human ovarian steroidogenesis
26. Normal-range FMR1 repeat genotypes and correlation with serum anti-müllerian hormone (AMH), cycle day 3 FSH (D3FSH), antral follicle count (AFC) and incidence of diminished ovarian reserve (DOR)
27. Ultrashort flare GnRH agonist with GnRH antagonist (MDA/Ant) results in a lower cancellation rate compared with clomiphene citrate/ gonadotropins (CC/Gnd) for poor responder (PR) patients
28. Extended blastocyst culture– is there uniformity in the criteria used by IVF labs?
29. IVF outcomes after preimplantation genetic diagnosis (PGD) for translocation carriers using microarray comparative genomic hybridization (aCGH) versus fluorescence in-situ hybridization (FISH)
30. Predicting successful induction of oocyte maturation after gonadotropin-releasing hormone agonist (GnRHa) trigger
31. Dual trigger with gonadotropin releasing hormone agonist (GnRHa) and human chorionic gonadotropin (hCG) for the treatment of ‘immature oocyte syndrome’ (IOS)
32. Potential reasons for patients not pursuing fertility preservation after referral for consultation and counseling
33. Cleavage stage versus blastocyst stage embryo transfer in frozen-thawed assisted conception cycles
34. Decreasing IVF-related multiple gestations: impact of an educational intervention on patients' desires to transfer multiple embryos
35. Luteal phase estradiol (LP) versus luteal phase estradiol and antagonist (LPG)protocol for controlled ovarian stimulation prior to IVF in poor responders
36. Follicular flare response does not predict in vitro fertilization (IVF) success in poor responders undergoing controlled ovarian hyperstimulation (COH) using microdose leuprolide (MDL)
37. P-798
38. P-104
39. P-878
40. P-306
41. P-703
42. O-280
43. O-276
44. Prevention of Ovarian Hyperstimulation Syndrome (OHSS) With the Use of Gonadotropin Releasing Hormone (GnRH) Agonist to Trigger Final Oocyte Maturation After Cotreatment With GnRH Antagonist in Patients With Polycystic Ovarian Syndrome (PCOS) or Previous High Response Undergoing IVF Treatment—A Prospective Randomized Clinical Trial
45. A Prospective Randomized Trial Evaluating the Effect of Luteal Phase Estradiol Supplementation on the Success of IVF Treatment
46. Serum Estradiol Level on Day of Embryo Transfer Is Associated With Implantation and Pregnancy Rates
47. The Role of Endometrial Biopsy in the Evaluation of Recurrent Implantation Failure
48. Should In Vitro Fertilization Cycles Be Canceled in Women 40 Years of Age and Older Who Produce Four or Less Oocytes?
49. The Use of GnRH Agonist to Trigger Final Stages of Oocyte Maturation in Patients with Polycystic Ovarian Syndrome (PCOS) and High Responders During IVF Treatment
50. The Probability of Conception After Embryo Transfer Using Fresh or Cryo-Thawed Multicellular Embryos
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.